# IDEX CORP (IEX) FY2026 Q3 Revenue by Business Segment (3 categories)

- Company: IDEX CORP (IEX)
- Statement: IDEX CORP (IEX) FY2026 Q3 P&L / Income Statement, https://plicit.ai/financials/iex/fy2026-q3-income-statement
- Period: 2026-07-01 to 2026-09-30
- Filing: Q3 FY2026 10-Q, filed 2026-10-28, accession number 0000832101-26-000029
- Page: https://plicit.ai/financials/iex/fy2026-q3-income-statement/revenue-by-business-segment-3-categories
- Chart image: https://plicit.ai/charts/iex-fy2026-q3-revenue-by-business-segment-3-categories-sankey.png

## Chart details: Revenue by Business Segment (3 categories)

Income statement for 2026-07-01 through 2026-09-30. View: Business segment (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 951,700,000 US dollars
- **Cost of sales**: 522,200,000 US dollars
- **Gross profit**: 429,500,000 US dollars
- **Operating expenses (calculated)**: 221,500,000 US dollars
- **Operating income**: 208,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 15,300,000 US dollars
- **Income before income taxes**: 192,700,000 US dollars
- **Provision for income taxes**: 48,700,000 US dollars
- **Net income**: 144,000,000 US dollars
- **Health & Science Technologies**: 432,500,000 US dollars
- **Fluid & Metering Technologies**: 327,800,000 US dollars
- **Fire & Safety/Diversified Products**: 191,400,000 US dollars
- **Selling, general and administrative expenses**: 218,100,000 US dollars
- **Restructuring expenses and asset impairments**: 3,400,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to IDEX CORP: $144.10 M; to noncontrolling interests: −$100.00 K.

## Key Takeaways

- Health & Science Technologies supplied $52.40 M of the $73.00 M sales rise, about 72% of it.
- Fluid & Metering Technologies grew only 3.5%, adding $11.00 M against Health & Science's $52.40 M.
- Restructuring charges hit $3.40 M, up from $0.10 M, partly for a facility closing in Health & Science.
- Restructuring has cost IDEX $13.60 M in the first nine months of 2026 and $18.30 M in 2025.

## The Unvarnished Truth

### Health & Science carried the growth as a facility there nears closure

IDEX's sales rose $73.00 M, and Health & Science Technologies supplied $52.40 M of that, about 72%. Its sales rose 14% from a year earlier, the fastest of the three segments. The same segment is where the company plans to close a facility. The filing says this quarter's restructuring expenses were $3.40 M, against $0.10 M a year earlier, and that they were mostly severance tied to employee reductions, including the anticipated closure of a facility in that segment.

Why would the fastest-growing part of the company need job cuts? The filing does not say which products or customers are moving. What it does say is that the nine-month restructuring line also carried $4.80 M of asset impairments in Fluid & Metering Technologies, the segment whose sales grew only 3.5% this quarter. The two facts sit side by side in the filing, and the filing does not connect them. A reader cannot tell from the segment table alone whether the impairment and the closure are in the same place.

What it means: the segment that carries the growth is also the one with a closure the filing calls anticipated, and restructuring has been a yearly habit, at $18.30 M in the first nine months of 2025 and $13.60 M in 2026. Will the closure end the charges, or will the next quarter bring another restructuring line? If restructuring is a yearly habit, what would make this year's cost one-time?

## Intelligent Insights for Investors

### Which of IDEX's businesses brings in the most sales?

Health & Science Technologies brought in 45% of sales this quarter, against 34% for Fluid & Metering Technologies, the next largest.

## Intelligent Insights for Lenders

### Which of IDEX's businesses generates the most sales per dollar of assets?

Fire & Safety/Diversified Products brought in $0.23 of revenue for each dollar of assets assigned to it at the end of the period, against $0.10 for Health & Science Technologies. That gap is a clue, not a verdict: the filing does not say how much of each segment's assets is acquired goodwill.

## Intelligent Insights for Employees

### Which of IDEX's businesses are being restructured?

The filing names a business: Health & Science Technologies, through the anticipated closure of a facility there. Restructuring charges were $3.40 M this quarter, against $0.10 M a year earlier, and the same MD&A section says they were mostly severance from employee reductions.
